Related Experiment Video
Updated: Feb 9, 2026
Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
The diagnosis and management of Kawasaki disease
1Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.
Insights
Kawasaki disease (KD) is a childhood vasculitis affecting coronary arteries. Early recognition and treatment are crucial to prevent cardiac damage, as diagnosis remains challenging.
Area of Science:
- Pediatric Rheumatology
- Cardiovascular Medicine
- Immunology
Background:
- Kawasaki disease (KD) is a leading cause of acquired heart disease in children, characterized by systemic vasculitis affecting coronary arteries.
- The unknown etiology of KD prevents a definitive diagnostic test, relying instead on clinical criteria with limited sensitivity and specificity.
- Suboptimal treatment in some regions highlights the need for improved awareness and diagnostic strategies.
Purpose of the Study:
- To enhance early recognition of Kawasaki disease by outlining diagnostic challenges and clinical clues.
- To provide evidence-based treatment recommendations for Kawasaki disease management.
- To underscore the importance of understanding KD epidemiology and clinical presentation for optimal pediatric care.
Main Methods:
- Review of clinical criteria for Kawasaki disease diagnosis.
- Analysis of treatment guidelines and supporting evidence.
- Discussion of epidemiological data and clinical presentation spectrum.
Main Results:
- Diagnosis of KD is challenging due to reliance on clinical criteria with poor individual performance.
- Early treatment is effective in preventing coronary artery damage in most children.
- Recent studies indicate suboptimal KD treatment and high rates of cardiac involvement in some areas.
Conclusions:
- Increased awareness of KD's epidemiology and varied presentation is essential for timely diagnosis.
- Adherence to evidence-based treatment guidelines can improve outcomes for children with Kawasaki disease.
- Further research is needed to elucidate KD etiology and develop diagnostic biomarkers.
Abstract:
Kawasaki disease (KD) is a systemic vasculitis of childhood with a predilection for the coronary arteries. It is the predominant cause of paediatric acquired heart disease in developed countries. The aetiology of KD remains unknown and consequently there is no diagnostic test. The diagnosis is made using a constellation of clinical criteria that in isolation have poor sensitivity and specificity. Early treatment prevents overt coronary artery damage in the majority of children. The long-term effects of childhood KD on later cardiovascular health remain unknown. A recent study showed that treatment of KD in Australia is suboptimal, with late diagnosis occurring in approximately half of the cases and an unacceptably high incidence of acute cardiac involvement. These guidelines highlight the difficulties in the diagnosis of KD and offer some clues that may assist early recognition of this important paediatric disease. They also detail current treatment recommendations and the evidence on which they are based. Increased awareness of the epidemiology and spectrum of the clinical presentation of KD is essential for early recognition and optimal management.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
01:23Peripheral Artery Disease V: Postoperative Nursing Management
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment